MALVERN, Pa., Jan. 31, 2025 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical ...

Investcorp, the Middle East’s largest alternative asset manager, could look at a deal with a strategic investor or an initial ...

Atlas Energy Solutions Inc. (NYSE: AESI) (“Atlas” or the “Company”) today announced the pricing of an upsized underwritten public offering (the “Offer ...

JP Morgan Asset Management has published its latest Global Alternatives Outlook which looks at the next 12-18 months and ...

J.P. Morgan, Morgan Stanley, and Jefferies are acting as joint book-running managers for the offering. UBS Investment Bank is acting as co-manager for the offering.

SAN FRANCISCO - 89bio, Inc. (NASDAQ:ETNB), a biopharmaceutical company specializing in liver and cardiometabolic diseases with a current market capitalization of $1.05 billion, has initiated a public ...

J.P. Morgan Asset Management's latest Global Alternatives Outlook highlights opportunities across PE, credit, real estate, ...

“A lot of companies have been waiting for the IPO window to open in the past couple of years, and so in many cases, private credit lenders are already invested in the company and ready to help with an ...

Global Offering composed of a reserved offering for qualified investors and a public offering for retail investors via the PrimaryBid platform Issue price for new shares set at 0.77 euro per ...